Agilent Technologies A · USD
Health Care · Life Sciences Tools & Services · US listing · 🇺🇸 United States
S&P 500
180.17
+3.10%
Close of 9 Nov 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Agilent Technologies
From its filings with the US Securities and Exchange Commission
Agilent Technologies is based in Santa Clara, California and is incorporated in Delaware. Its shares trade on NYSE under the ticker A. It is a member of the S&P 500. The SEC classifies its business as laboratory analytical instruments. In the fiscal year to 31 October 2025, it reported revenue of $6.95bn and net income of $1.30bn. At that date it held total assets of $12.73bn and shareholders' equity of $6.74bn.
Agilent Technologies, Inc. ("we", "Agilent" or the "company"), incorporated in Delaware in May 1999, is a global leader in life sciences, diagnostics and applied markets, providing application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow.
In November 2024, we announced a change in our organizational structure to support our market-focused, customer-centric strategy. Our former Diagnostics and Genomics segment combined with our liquid chromatography and liquid chromatography mass spectrometry instrument platforms to form our new Life Sciences and Diagnostics Markets segment. Our chemistries and supplies, laboratory automation, and software and informatics divisions moved from our former Life Sciences and Applied Markets segment to our Agilent CrossLab segment. The remaining divisions in our former Life Sciences and Applied Markets segment which includes our gas chromatography, gas chromatography mass spectrometry, remarketed instruments, spectroscopy and vacuum divisions formed our new Applied Markets segment.
Following this re-organization, we have three business segments - Life Sciences and Diagnostics Markets, Agilent CrossLab and Applied Markets, each of which comprises a reportable segment. All historical financial segment information has been recast to conform to this new presentation.
Quoted from its 10-K, filed 22 Dec 2025. Read the filing on SEC.gov ↗
Company facts
- Sector
- Health Care
- Industry
- Life Sciences Tools & Services
- Listed since
- 18 Nov 1999
- Employees
- 18,100
- Website
- agilent.com ↗
- Head office
- 5301 STEVENS CREEK BLVD, SANTA CLARA, CA, 95051
- Incorporated in
- DE
- Classification
- Laboratory Analytical Instruments
- Filer status
- Large accelerated filer
Leadership
Pay as last reported
- Mr. Boon Hwee KohIndependent Chairman of the Board$480,426
- Mr. Padraig McDonnellPresident, Chief Executive Officer, Director, since 2020$12.8m
- Mr. Adam ElinoffChief Financial Officer, Senior Vice President
- Ms. Meghan HensonChief Human Resources Officer, Senior Vice President
- Mr. Bret DimarcoSenior Vice President, Chief Legal Officer, Secretary$3.7m
- Mr. Jonah KirkwoodSenior Vice President, Chief Commercial Officer - Commercial Organization
- Dr. Simon MaySenior Vice President, President - Life Sciences and Diagnostics Markets Group$3.9m
- Ms. Angelica RiemannSenior Vice President, President - Agilent CrossLab Group$3.2m
- Mr. Mike ZhangSenior Vice President, President - Applied Markets Group
- Mr. Rodney GonsalvesVice President, Corporate Controller, Principal Accounting Officer$2.7m
- Ms. Mala AnandIndependent Director$325,426
- Dr. Otis BrawleyIndependent Director$325,426
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 87
- Environment
- 99
- Social
- 99
- Governance
- 63
- Direct emissions (scope 1)
- 20,460 t
- Energy emissions (scope 2)
- 48,159 t
- Value chain emissions (scope 3)
- 88,599 t
- Women in the workforce
- 38%
- Carbon reduction policy
- Yes
- Human rights policy
- Yes
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Agilent Technologies Inc is a renowned leader in the field of analytical instrumentation and diagnostics, with a strong global presence and extensive product offerings.
- The company has a robust research and development department, consistently innovating and introducing new technologies to stay ahead of the competition.
- Agilent has a well-established reputation for quality and reliability, earning the trust of customers across various industries.
Weaknesses
- Agilent's heavy reliance on a few key customers for a significant portion of its revenue poses a potential risk if those customer relationships weaken or end.
- The company faces intense competition, making it critical for Agilent to continuously differentiate its products and services to maintain its market share.
- Agilent's geographical concentration exposes it to potential risks associated with regional economic and political uncertainties.
Opportunities
- The global demand for analytical instrumentation and diagnostics is expected to grow, providing Agilent with opportunities to expand its market presence and revenue.
- Technological advancements in areas such as genomics, proteomics, and precision medicine present Agilent with opportunities to develop and sell cutting-edge solutions.
- Agilent can explore strategic partnerships and acquisitions to enhance its product portfolio and enter new markets.
Threats
- Economic downturns and market volatility pose threats to Agilent's financial performance as organizations may reduce spending on research and development.
- Agilent operates in a highly regulated industry, making compliance with changing regulations and standards a significant challenge.
- Emerging competitors and disruptive technologies have the potential to disrupt Agilent's market position and erode its customer base.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.